Commerce Bank Seagen Inc. Transaction History

Commerce Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $11,873 - $13,401	-62 Reduced 1.4%	4,352 $923,000
Q2 2023 Aug 08, 2023	BUY	$187.64 - $206.25 $1,688 - $1,856	9 Added 0.2%	4,414 $849,000
Q1 2023 May 04, 2023	SELL	$127.59 - $203.08 $5,358 - $8,529	-42 Reduced 0.94%	4,405 $891,000
Q4 2022 Feb 10, 2023	SELL	$117.37 - $139.17 $5,046 - $5,984	-43 Reduced 0.96%	4,447 $571,000
Q3 2022 Nov 04, 2022	SELL	$135.27 - $180.11 $1,082 - $1,440	-8 Reduced 0.18%	4,490 $614,000
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $8,704 - $14,346	80 Added 1.81%	4,498 $796,000
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $22,008 - $29,044	184 Added 4.35%	4,418 $636,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $34,644 - $46,378	243 Added 6.09%	4,234 $655,000
Q3 2021 Nov 09, 2021	SELL	$142.45 - $169.82 $213,247 - $254,220	-1,497 Reduced 27.28%	3,991 $678,000
Q2 2021 Aug 09, 2021	BUY	$135.08 - $161.1 $4,862 - $5,799	36 Added 0.66%	5,488 $866,000
Q1 2021 May 05, 2021	SELL	$137.51 - $190.8 $3.38 Million - $4.69 Million	-24,589 Reduced 81.85%	5,452 $757,000
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $4.95 Million - $6.37 Million	30,041 New	30,041 $5.26 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

Stay updated on Commerce Bank with notifications on news.